Cixutumumab (Anti-IGF1R / CD221)

Synonyms: IMC-A12

Cixutumumab (Anti-IGF1R / CD221) is a humanized monoclonal antibody with high affinity that targets type-1-insulin-like growth factor receptor (IGF-1R).It shows broad-spectrum anti-tumour activity and can be used in studies of sarcomas, neuroblastoma, wilms tumor, lung cancer, malignancies, leukaemia, non-small cell lung cancer and prostate cancer. MW :150 KD.

Cixutumumab (Anti-IGF1R / CD221)

Purity & Quality Control

≥99

Biological Activity

Description Cixutumumab (Anti-IGF1R / CD221) is a humanized monoclonal antibody with high affinity that targets type-1-insulin-like growth factor receptor (IGF-1R).It shows broad-spectrum anti-tumour activity and can be used in studies of sarcomas, neuroblastoma, wilms tumor, lung cancer, malignancies, leukaemia, non-small cell lung cancer and prostate cancer. MW :150 KD.

Product Details

CAS No. 947687-12-9
Molecular Weight 150
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Cixutumumab (Anti-IGF1R / CD221) | Cixutumumab (Anti-IGF1R / CD221) supplier | purchase Cixutumumab (Anti-IGF1R / CD221) | Cixutumumab (Anti-IGF1R / CD221) cost | Cixutumumab (Anti-IGF1R / CD221) manufacturer | order Cixutumumab (Anti-IGF1R / CD221) | Cixutumumab (Anti-IGF1R / CD221) distributor